Skip to main content
Top
Published in: Clinical Research in Cardiology 11/2017

Open Access 01-11-2017 | Original Paper

Treatment of chronic heart failure in Germany: a retrospective database study

Authors: Stefan Störk, Renate Handrock, Josephine Jacob, Jochen Walker, Frederico Calado, Raquel Lahoz, Stephan Hupfer, Sven Klebs

Published in: Clinical Research in Cardiology | Issue 11/2017

Login to get access

Abstract

Background

Adherence to treatment guidelines affects outcomes in patients with chronic heart failure (HF). We investigated patient pathways and treatment patterns for HF in Germany.

Methods

This retrospective study used anonymous healthcare claims data from the German Health Risk Institute on individuals with statutory health insurance. Patients with uninterrupted data from 1 January 2009 to 31 December 2013 or death (whichever occurred first), and ≥2 recorded HF-related diagnoses in 2011, were included. Patients with newly diagnosed HF were identified. Use of treatment patterns recommended by the European Society of Cardiology (2008) and German Nationale VersorgungsLeitlinien (2011) guidelines was evaluated.

Results

Of 123,925 patients with HF, 21.3% were newly diagnosed. Overall, 63.2% of new HF diagnoses were made in the ambulatory setting; 61.6% of these were made by family practitioners and 14.8% by cardiologists. In the ambulatory setting, family practitioners were primarily responsible for treatment; specialists in internal medicine (70.3% cardiologists) were mainly responsible for performing HF-related technical diagnostics. One-fifth (20.9%) of patients received a New York Heart Association (NYHA) classification; 45.1% of these received a guideline-based treatment pattern. Application of the recommended treatment pattern decreased with advancing disease severity (NYHA class IV: 21.1% application) and older age (≥90 years: 28.3% application).

Conclusions

Family practitioners play a key role in the diagnosis and initial treatment of HF in Germany. A substantial proportion of patients do not receive guideline-recommended pharmacotherapy. These findings should be reflected in the planning of national disease management programmes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mehrhof F, Loffler M, Gelbrich G et al (2010) A network against failing hearts—introducing the German “Competence Network Heart Failure”. Int J Cardiol 145:135–138CrossRefPubMed Mehrhof F, Loffler M, Gelbrich G et al (2010) A network against failing hearts—introducing the German “Competence Network Heart Failure”. Int J Cardiol 145:135–138CrossRefPubMed
2.
go back to reference Tebbe U, Tschope C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Strunz AM, Lins K, Bohm M (2014) Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol 103:665–673CrossRefPubMed Tebbe U, Tschope C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Strunz AM, Lins K, Bohm M (2014) Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol 103:665–673CrossRefPubMed
3.
go back to reference Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed
5.
go back to reference Zugck C, Franke J, Gelbrich G et al (2012) Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol 101:263–272CrossRefPubMed Zugck C, Franke J, Gelbrich G et al (2012) Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol 101:263–272CrossRefPubMed
6.
go back to reference Rutten FH, Grobbee DE, Hoes AW (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5:337–344CrossRefPubMed Rutten FH, Grobbee DE, Hoes AW (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5:337–344CrossRefPubMed
7.
go back to reference Franke J, Zugck C, Wolter JS et al (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101:1–10CrossRefPubMed Franke J, Zugck C, Wolter JS et al (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101:1–10CrossRefPubMed
8.
go back to reference Ke M, Zou D, Yuan Y, Li Y, Lin L, Hao J, Hou X, Kim HJ (2012) Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil 24:999-e541CrossRefPubMedPubMedCentral Ke M, Zou D, Yuan Y, Li Y, Lin L, Hao J, Hou X, Kim HJ (2012) Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil 24:999-e541CrossRefPubMedPubMedCentral
9.
go back to reference Braunwald E (1997) Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369CrossRefPubMed Braunwald E (1997) Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369CrossRefPubMed
10.
go back to reference Braun V, Heintze C, Rufer V, Welke J, Stein T, Mehrhof F, Dini L (2011) Innovative strategy for implementing chronic heart failure guidelines among family physicians in different healthcare settings in Berlin. Eur J Heart Fail 13:93–99CrossRefPubMed Braun V, Heintze C, Rufer V, Welke J, Stein T, Mehrhof F, Dini L (2011) Innovative strategy for implementing chronic heart failure guidelines among family physicians in different healthcare settings in Berlin. Eur J Heart Fail 13:93–99CrossRefPubMed
11.
go back to reference Dini L, Heintze C, Welke J, Stein T, Rufer V, Braun V (2010) Are there any differences in guideline adherence to pharmacotherapy of heart failure between individual GP practices and Medical Care Centres (MCCs)? Z Evid Fortbild Qual Gesundhwes 104:113–119CrossRefPubMed Dini L, Heintze C, Welke J, Stein T, Rufer V, Braun V (2010) Are there any differences in guideline adherence to pharmacotherapy of heart failure between individual GP practices and Medical Care Centres (MCCs)? Z Evid Fortbild Qual Gesundhwes 104:113–119CrossRefPubMed
13.
go back to reference Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442CrossRefPubMed Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442CrossRefPubMed
15.
go back to reference Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216CrossRefPubMed Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216CrossRefPubMed
16.
go back to reference Stork S, Hense HW, Zentgraf C, Uebelacker I, Jahns R, Ertl G, Angermann CE (2008) Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. Eur J Heart Fail 10:1236–1245CrossRefPubMed Stork S, Hense HW, Zentgraf C, Uebelacker I, Jahns R, Ertl G, Angermann CE (2008) Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. Eur J Heart Fail 10:1236–1245CrossRefPubMed
17.
go back to reference Bohm M, Tschope C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Lins K, Strunz AM, Tebbe U (2015) Treatment of heart failure in real-world clinical practice: findings from the REFLECT-HF registry in patients with NYHA class II symptoms and a reduced ejection fraction. Clin Cardiol 38:200–207CrossRefPubMed Bohm M, Tschope C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Lins K, Strunz AM, Tebbe U (2015) Treatment of heart failure in real-world clinical practice: findings from the REFLECT-HF registry in patients with NYHA class II symptoms and a reduced ejection fraction. Clin Cardiol 38:200–207CrossRefPubMed
18.
go back to reference von Scheidt W, Zugck C, Pauschinger M et al (2014) Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol 103:1006–1014CrossRef von Scheidt W, Zugck C, Pauschinger M et al (2014) Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol 103:1006–1014CrossRef
19.
go back to reference Andersohn F, Walker J (2016) Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiol Drug Saf 25:106–109CrossRefPubMed Andersohn F, Walker J (2016) Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiol Drug Saf 25:106–109CrossRefPubMed
21.
go back to reference Maggioni AP, Anker SD, Dahlstrom U et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 15:1173–1184CrossRefPubMed Maggioni AP, Anker SD, Dahlstrom U et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 15:1173–1184CrossRefPubMed
22.
go back to reference Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS (2017) Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. doi:10.1002/ejhf.887 (Epub ahead of print) Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS (2017) Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. doi:10.​1002/​ejhf.​887 (Epub ahead of print)
23.
go back to reference Allen LA, Shetterly SM, Peterson PN et al (2014) Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail 7:43–50CrossRefPubMed Allen LA, Shetterly SM, Peterson PN et al (2014) Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail 7:43–50CrossRefPubMed
24.
25.
go back to reference Angermann CE, Stork S, Gelbrich G, Faller H, Jahns R, Frantz S, Loeffler M, Ertl G (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5:25–35CrossRefPubMed Angermann CE, Stork S, Gelbrich G, Faller H, Jahns R, Frantz S, Loeffler M, Ertl G (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5:25–35CrossRefPubMed
26.
go back to reference Guder G, Stork S, Gelbrich G et al (2015) Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail 17:442–452CrossRefPubMed Guder G, Stork S, Gelbrich G et al (2015) Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail 17:442–452CrossRefPubMed
Metadata
Title
Treatment of chronic heart failure in Germany: a retrospective database study
Authors
Stefan Störk
Renate Handrock
Josephine Jacob
Jochen Walker
Frederico Calado
Raquel Lahoz
Stephan Hupfer
Sven Klebs
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 11/2017
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-017-1138-6

Other articles of this Issue 11/2017

Clinical Research in Cardiology 11/2017 Go to the issue